Cambrex Appoints Thomas Rohrer Director, Cell Culture Manufacturing
"We are delighted that Tom has joined Cambrex as an experienced resource to lead the scale-up of our cell culture manufacturing capabilities, the fastest growing segment of the biologics market," commented Gary L. Mossman, President and CEO, Cambrex Pharma and Biopharmaceuticals businesses.
Thomas Rohrer joins Cambrex with a wealth of experience in large-scale upstream, recovery and purification development of mammalian, yeast and bacterial expression systems. Most recently at Human Genome Sciences, Mr. Rohrer was Director of Fermentation and Mammalian Cell Culture Process Development. He has 23 years of process development/ clinical manufacturing and managerial experience. Prior to Human Genome Sciences, Mr. Rohrer was Senior Process Engineer, Upstream Process and Recovery Development at Otsuka America Pharmaceutical, Inc. in Rockville, MD. Mr. Rohrer's experience includes process scale-up; production and recovery of cytokines, growth factors, antibodies; and natural products for domestic and international pharmaceutical R&D using both prokaryotic and eukaryotic expression systems.
Other news from the department people
Most read news
More news from our other portals
See the theme worlds for related content
Topic world biopharmaceutical manufacturing
Biopharmaceutical production plays a crucial role in the development and manufacture of biologics, which are essential for the treatment of various serious diseases. Various key technologies and processes of the modern biopharmaceutical industry are used, such as cell cultures, fermentation processes and the purification of biological substances, which are necessary for the production of vaccines, monoclonal antibodies and other biological drugs.
Topic world biopharmaceutical manufacturing
Biopharmaceutical production plays a crucial role in the development and manufacture of biologics, which are essential for the treatment of various serious diseases. Various key technologies and processes of the modern biopharmaceutical industry are used, such as cell cultures, fermentation processes and the purification of biological substances, which are necessary for the production of vaccines, monoclonal antibodies and other biological drugs.